Global Butorphanol Market

Butorphanol Comprehensive Study by Type (Spray, Injection, Tablet), Application (Human, Veterinary), Drug (Prescripted, OTC) Players and Region - Global Market Outlook to 2026

Butorphanol Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Global Butorphanol Market Overview:
Butorphanol is used to treat moderate to severe pain. It is also used as part of anesthesia for surgery, or during early labor. Also, Butorphanol is an opiate agonist used by some veterinarians primarily as an anti-tussive, to help alleviate coughing. In some cases, it can be used to treat pain in animals, such as colic in horses, or as a pre-anesthetic.

Growth Drivers
  • Increasing Demand for Long-Term Pain Management among the Geriatric Population
  • Growing Prevalence of Animal Diseases Causing Pain and Inflammation

Market Trends
  • Growth in Clinical Trials

Roadblocks
  • Side Effects of the Butorphanol

Opportunities
  • Increasing Popularity of Non-Conventional and Non-Pharmaceutical Treatment Techniques
  • Untapped Emerging Markets

Challenges
  • Low Animal Healthcare Awareness in Emerging Markets
  • Stringent Regulatory Approval Process for Pain Management Drugs


Competitive Landscape:
The companies are exploring the market by adopting expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions across the globe to avail of competitive advantage through combined collaborations.
Some of the key players profiled in the report are Hikma Pharmaceuticals plc (United Kingdom), Richter Pharma Ag (Austria), Mylan N.V. (United States), Pfizer Inc. (United States), Sanochemia Pharmazeutika AG (Austria), Novex Pharma (Egypt), Selectavet (Germany), Bristol Myers Squibb (United States), Dechra Pharmaceuticals PLC (United Kingdom) and Merck Group (Germany). Additionally, following companies can also be profiled that are part of our coverage like Apothecon Pharmaceuticals (India) and Faunapharma (Finland). Analyst at AMA Research see United States Players to retain maximum share of Global Butorphanol market by 2026. Considering Market by Drug, the sub-segment i.e. Prescripted will boost the Butorphanol market.

What Can be Explored with the Butorphanol Market Study
 Gain Market Understanding
 Identify Growth Opportunities
 Analyze and Measure the Global Butorphanol Market by Identifying Investment across various Industry Verticals
 Understand the Trends that will drive Future Changes in Butorphanol
 Understand the Competitive Scenario
- Track Right Markets
- Identify the Right Verticals

Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Butorphanol market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Butorphanol market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Manufacturers of Butorphanol, Suppliers of Butorphanol, Wholesalers, Distributors, and Retailers of Butorphanol, Healthcare Industry, Governmental Bodies and Research Firms.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.

Report Objectives / Segmentation Covered

By Type
  • Spray
  • Injection
  • Tablet
By Application
  • Human
  • Veterinary
By Drug
  • Prescripted
  • OTC

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Demand for Long-Term Pain Management among the Geriatric Population
      • 3.2.2. Growing Prevalence of Animal Diseases Causing Pain and Inflammation
    • 3.3. Market Challenges
      • 3.3.1. Low Animal Healthcare Awareness in Emerging Markets
      • 3.3.2. Stringent Regulatory Approval Process for Pain Management Drugs
    • 3.4. Market Trends
      • 3.4.1. Growth in Clinical Trials
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Butorphanol, by Type, Application, Drug and Region (value, volume and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Butorphanol (Value)
      • 5.2.1. Global Butorphanol by: Type (Value)
        • 5.2.1.1. Spray
        • 5.2.1.2. Injection
        • 5.2.1.3. Tablet
      • 5.2.2. Global Butorphanol by: Application (Value)
        • 5.2.2.1. Human
        • 5.2.2.2. Veterinary
      • 5.2.3. Global Butorphanol by: Drug (Value)
        • 5.2.3.1. Prescripted
        • 5.2.3.2. OTC
      • 5.2.4. Global Butorphanol Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Butorphanol (Volume)
      • 5.3.1. Global Butorphanol by: Type (Volume)
        • 5.3.1.1. Spray
        • 5.3.1.2. Injection
        • 5.3.1.3. Tablet
      • 5.3.2. Global Butorphanol by: Application (Volume)
        • 5.3.2.1. Human
        • 5.3.2.2. Veterinary
      • 5.3.3. Global Butorphanol by: Drug (Volume)
        • 5.3.3.1. Prescripted
        • 5.3.3.2. OTC
      • 5.3.4. Global Butorphanol Region
        • 5.3.4.1. South America
          • 5.3.4.1.1. Brazil
          • 5.3.4.1.2. Argentina
          • 5.3.4.1.3. Rest of South America
        • 5.3.4.2. Asia Pacific
          • 5.3.4.2.1. China
          • 5.3.4.2.2. Japan
          • 5.3.4.2.3. India
          • 5.3.4.2.4. South Korea
          • 5.3.4.2.5. Taiwan
          • 5.3.4.2.6. Australia
          • 5.3.4.2.7. Rest of Asia-Pacific
        • 5.3.4.3. Europe
          • 5.3.4.3.1. Germany
          • 5.3.4.3.2. France
          • 5.3.4.3.3. Italy
          • 5.3.4.3.4. United Kingdom
          • 5.3.4.3.5. Netherlands
          • 5.3.4.3.6. Rest of Europe
        • 5.3.4.4. MEA
          • 5.3.4.4.1. Middle East
          • 5.3.4.4.2. Africa
        • 5.3.4.5. North America
          • 5.3.4.5.1. United States
          • 5.3.4.5.2. Canada
          • 5.3.4.5.3. Mexico
    • 5.4. Global Butorphanol (Price)
      • 5.4.1. Global Butorphanol by: Type (Price)
  • 6. Butorphanol: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Hikma Pharmaceuticals plc (United Kingdom)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Richter Pharma Ag (Austria)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Mylan N.V. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Pfizer Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Sanochemia Pharmazeutika AG (Austria)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Novex Pharma (Egypt)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Selectavet (Germany)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Bristol Myers Squibb (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Dechra Pharmaceuticals PLC (United Kingdom)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Merck Group (Germany)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Butorphanol Sale, by Type, Application, Drug and Region (value, volume and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Butorphanol (Value)
      • 7.2.1. Global Butorphanol by: Type (Value)
        • 7.2.1.1. Spray
        • 7.2.1.2. Injection
        • 7.2.1.3. Tablet
      • 7.2.2. Global Butorphanol by: Application (Value)
        • 7.2.2.1. Human
        • 7.2.2.2. Veterinary
      • 7.2.3. Global Butorphanol by: Drug (Value)
        • 7.2.3.1. Prescripted
        • 7.2.3.2. OTC
      • 7.2.4. Global Butorphanol Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Butorphanol (Volume)
      • 7.3.1. Global Butorphanol by: Type (Volume)
        • 7.3.1.1. Spray
        • 7.3.1.2. Injection
        • 7.3.1.3. Tablet
      • 7.3.2. Global Butorphanol by: Application (Volume)
        • 7.3.2.1. Human
        • 7.3.2.2. Veterinary
      • 7.3.3. Global Butorphanol by: Drug (Volume)
        • 7.3.3.1. Prescripted
        • 7.3.3.2. OTC
      • 7.3.4. Global Butorphanol Region
        • 7.3.4.1. South America
          • 7.3.4.1.1. Brazil
          • 7.3.4.1.2. Argentina
          • 7.3.4.1.3. Rest of South America
        • 7.3.4.2. Asia Pacific
          • 7.3.4.2.1. China
          • 7.3.4.2.2. Japan
          • 7.3.4.2.3. India
          • 7.3.4.2.4. South Korea
          • 7.3.4.2.5. Taiwan
          • 7.3.4.2.6. Australia
          • 7.3.4.2.7. Rest of Asia-Pacific
        • 7.3.4.3. Europe
          • 7.3.4.3.1. Germany
          • 7.3.4.3.2. France
          • 7.3.4.3.3. Italy
          • 7.3.4.3.4. United Kingdom
          • 7.3.4.3.5. Netherlands
          • 7.3.4.3.6. Rest of Europe
        • 7.3.4.4. MEA
          • 7.3.4.4.1. Middle East
          • 7.3.4.4.2. Africa
        • 7.3.4.5. North America
          • 7.3.4.5.1. United States
          • 7.3.4.5.2. Canada
          • 7.3.4.5.3. Mexico
    • 7.4. Global Butorphanol (Price)
      • 7.4.1. Global Butorphanol by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Butorphanol: by Type(USD Million)
  • Table 2. Butorphanol Spray , by Region USD Million (2015-2020)
  • Table 3. Butorphanol Injection , by Region USD Million (2015-2020)
  • Table 4. Butorphanol Tablet , by Region USD Million (2015-2020)
  • Table 5. Butorphanol: by Application(USD Million)
  • Table 6. Butorphanol Human , by Region USD Million (2015-2020)
  • Table 7. Butorphanol Veterinary , by Region USD Million (2015-2020)
  • Table 8. Butorphanol: by Drug(USD Million)
  • Table 9. Butorphanol Prescripted , by Region USD Million (2015-2020)
  • Table 10. Butorphanol OTC , by Region USD Million (2015-2020)
  • Table 11. South America Butorphanol, by Country USD Million (2015-2020)
  • Table 12. South America Butorphanol, by Type USD Million (2015-2020)
  • Table 13. South America Butorphanol, by Application USD Million (2015-2020)
  • Table 14. South America Butorphanol, by Drug USD Million (2015-2020)
  • Table 15. Brazil Butorphanol, by Type USD Million (2015-2020)
  • Table 16. Brazil Butorphanol, by Application USD Million (2015-2020)
  • Table 17. Brazil Butorphanol, by Drug USD Million (2015-2020)
  • Table 18. Argentina Butorphanol, by Type USD Million (2015-2020)
  • Table 19. Argentina Butorphanol, by Application USD Million (2015-2020)
  • Table 20. Argentina Butorphanol, by Drug USD Million (2015-2020)
  • Table 21. Rest of South America Butorphanol, by Type USD Million (2015-2020)
  • Table 22. Rest of South America Butorphanol, by Application USD Million (2015-2020)
  • Table 23. Rest of South America Butorphanol, by Drug USD Million (2015-2020)
  • Table 24. Asia Pacific Butorphanol, by Country USD Million (2015-2020)
  • Table 25. Asia Pacific Butorphanol, by Type USD Million (2015-2020)
  • Table 26. Asia Pacific Butorphanol, by Application USD Million (2015-2020)
  • Table 27. Asia Pacific Butorphanol, by Drug USD Million (2015-2020)
  • Table 28. China Butorphanol, by Type USD Million (2015-2020)
  • Table 29. China Butorphanol, by Application USD Million (2015-2020)
  • Table 30. China Butorphanol, by Drug USD Million (2015-2020)
  • Table 31. Japan Butorphanol, by Type USD Million (2015-2020)
  • Table 32. Japan Butorphanol, by Application USD Million (2015-2020)
  • Table 33. Japan Butorphanol, by Drug USD Million (2015-2020)
  • Table 34. India Butorphanol, by Type USD Million (2015-2020)
  • Table 35. India Butorphanol, by Application USD Million (2015-2020)
  • Table 36. India Butorphanol, by Drug USD Million (2015-2020)
  • Table 37. South Korea Butorphanol, by Type USD Million (2015-2020)
  • Table 38. South Korea Butorphanol, by Application USD Million (2015-2020)
  • Table 39. South Korea Butorphanol, by Drug USD Million (2015-2020)
  • Table 40. Taiwan Butorphanol, by Type USD Million (2015-2020)
  • Table 41. Taiwan Butorphanol, by Application USD Million (2015-2020)
  • Table 42. Taiwan Butorphanol, by Drug USD Million (2015-2020)
  • Table 43. Australia Butorphanol, by Type USD Million (2015-2020)
  • Table 44. Australia Butorphanol, by Application USD Million (2015-2020)
  • Table 45. Australia Butorphanol, by Drug USD Million (2015-2020)
  • Table 46. Rest of Asia-Pacific Butorphanol, by Type USD Million (2015-2020)
  • Table 47. Rest of Asia-Pacific Butorphanol, by Application USD Million (2015-2020)
  • Table 48. Rest of Asia-Pacific Butorphanol, by Drug USD Million (2015-2020)
  • Table 49. Europe Butorphanol, by Country USD Million (2015-2020)
  • Table 50. Europe Butorphanol, by Type USD Million (2015-2020)
  • Table 51. Europe Butorphanol, by Application USD Million (2015-2020)
  • Table 52. Europe Butorphanol, by Drug USD Million (2015-2020)
  • Table 53. Germany Butorphanol, by Type USD Million (2015-2020)
  • Table 54. Germany Butorphanol, by Application USD Million (2015-2020)
  • Table 55. Germany Butorphanol, by Drug USD Million (2015-2020)
  • Table 56. France Butorphanol, by Type USD Million (2015-2020)
  • Table 57. France Butorphanol, by Application USD Million (2015-2020)
  • Table 58. France Butorphanol, by Drug USD Million (2015-2020)
  • Table 59. Italy Butorphanol, by Type USD Million (2015-2020)
  • Table 60. Italy Butorphanol, by Application USD Million (2015-2020)
  • Table 61. Italy Butorphanol, by Drug USD Million (2015-2020)
  • Table 62. United Kingdom Butorphanol, by Type USD Million (2015-2020)
  • Table 63. United Kingdom Butorphanol, by Application USD Million (2015-2020)
  • Table 64. United Kingdom Butorphanol, by Drug USD Million (2015-2020)
  • Table 65. Netherlands Butorphanol, by Type USD Million (2015-2020)
  • Table 66. Netherlands Butorphanol, by Application USD Million (2015-2020)
  • Table 67. Netherlands Butorphanol, by Drug USD Million (2015-2020)
  • Table 68. Rest of Europe Butorphanol, by Type USD Million (2015-2020)
  • Table 69. Rest of Europe Butorphanol, by Application USD Million (2015-2020)
  • Table 70. Rest of Europe Butorphanol, by Drug USD Million (2015-2020)
  • Table 71. MEA Butorphanol, by Country USD Million (2015-2020)
  • Table 72. MEA Butorphanol, by Type USD Million (2015-2020)
  • Table 73. MEA Butorphanol, by Application USD Million (2015-2020)
  • Table 74. MEA Butorphanol, by Drug USD Million (2015-2020)
  • Table 75. Middle East Butorphanol, by Type USD Million (2015-2020)
  • Table 76. Middle East Butorphanol, by Application USD Million (2015-2020)
  • Table 77. Middle East Butorphanol, by Drug USD Million (2015-2020)
  • Table 78. Africa Butorphanol, by Type USD Million (2015-2020)
  • Table 79. Africa Butorphanol, by Application USD Million (2015-2020)
  • Table 80. Africa Butorphanol, by Drug USD Million (2015-2020)
  • Table 81. North America Butorphanol, by Country USD Million (2015-2020)
  • Table 82. North America Butorphanol, by Type USD Million (2015-2020)
  • Table 83. North America Butorphanol, by Application USD Million (2015-2020)
  • Table 84. North America Butorphanol, by Drug USD Million (2015-2020)
  • Table 85. United States Butorphanol, by Type USD Million (2015-2020)
  • Table 86. United States Butorphanol, by Application USD Million (2015-2020)
  • Table 87. United States Butorphanol, by Drug USD Million (2015-2020)
  • Table 88. Canada Butorphanol, by Type USD Million (2015-2020)
  • Table 89. Canada Butorphanol, by Application USD Million (2015-2020)
  • Table 90. Canada Butorphanol, by Drug USD Million (2015-2020)
  • Table 91. Mexico Butorphanol, by Type USD Million (2015-2020)
  • Table 92. Mexico Butorphanol, by Application USD Million (2015-2020)
  • Table 93. Mexico Butorphanol, by Drug USD Million (2015-2020)
  • Table 94. Butorphanol Sales: by Type(K Unit)
  • Table 95. Butorphanol Sales Spray , by Region K Unit (2015-2020)
  • Table 96. Butorphanol Sales Injection , by Region K Unit (2015-2020)
  • Table 97. Butorphanol Sales Tablet , by Region K Unit (2015-2020)
  • Table 98. Butorphanol Sales: by Application(K Unit)
  • Table 99. Butorphanol Sales Human , by Region K Unit (2015-2020)
  • Table 100. Butorphanol Sales Veterinary , by Region K Unit (2015-2020)
  • Table 101. Butorphanol Sales: by Drug(K Unit)
  • Table 102. Butorphanol Sales Prescripted , by Region K Unit (2015-2020)
  • Table 103. Butorphanol Sales OTC , by Region K Unit (2015-2020)
  • Table 104. South America Butorphanol Sales, by Country K Unit (2015-2020)
  • Table 105. South America Butorphanol Sales, by Type K Unit (2015-2020)
  • Table 106. South America Butorphanol Sales, by Application K Unit (2015-2020)
  • Table 107. South America Butorphanol Sales, by Drug K Unit (2015-2020)
  • Table 108. Brazil Butorphanol Sales, by Type K Unit (2015-2020)
  • Table 109. Brazil Butorphanol Sales, by Application K Unit (2015-2020)
  • Table 110. Brazil Butorphanol Sales, by Drug K Unit (2015-2020)
  • Table 111. Argentina Butorphanol Sales, by Type K Unit (2015-2020)
  • Table 112. Argentina Butorphanol Sales, by Application K Unit (2015-2020)
  • Table 113. Argentina Butorphanol Sales, by Drug K Unit (2015-2020)
  • Table 114. Rest of South America Butorphanol Sales, by Type K Unit (2015-2020)
  • Table 115. Rest of South America Butorphanol Sales, by Application K Unit (2015-2020)
  • Table 116. Rest of South America Butorphanol Sales, by Drug K Unit (2015-2020)
  • Table 117. Asia Pacific Butorphanol Sales, by Country K Unit (2015-2020)
  • Table 118. Asia Pacific Butorphanol Sales, by Type K Unit (2015-2020)
  • Table 119. Asia Pacific Butorphanol Sales, by Application K Unit (2015-2020)
  • Table 120. Asia Pacific Butorphanol Sales, by Drug K Unit (2015-2020)
  • Table 121. China Butorphanol Sales, by Type K Unit (2015-2020)
  • Table 122. China Butorphanol Sales, by Application K Unit (2015-2020)
  • Table 123. China Butorphanol Sales, by Drug K Unit (2015-2020)
  • Table 124. Japan Butorphanol Sales, by Type K Unit (2015-2020)
  • Table 125. Japan Butorphanol Sales, by Application K Unit (2015-2020)
  • Table 126. Japan Butorphanol Sales, by Drug K Unit (2015-2020)
  • Table 127. India Butorphanol Sales, by Type K Unit (2015-2020)
  • Table 128. India Butorphanol Sales, by Application K Unit (2015-2020)
  • Table 129. India Butorphanol Sales, by Drug K Unit (2015-2020)
  • Table 130. South Korea Butorphanol Sales, by Type K Unit (2015-2020)
  • Table 131. South Korea Butorphanol Sales, by Application K Unit (2015-2020)
  • Table 132. South Korea Butorphanol Sales, by Drug K Unit (2015-2020)
  • Table 133. Taiwan Butorphanol Sales, by Type K Unit (2015-2020)
  • Table 134. Taiwan Butorphanol Sales, by Application K Unit (2015-2020)
  • Table 135. Taiwan Butorphanol Sales, by Drug K Unit (2015-2020)
  • Table 136. Australia Butorphanol Sales, by Type K Unit (2015-2020)
  • Table 137. Australia Butorphanol Sales, by Application K Unit (2015-2020)
  • Table 138. Australia Butorphanol Sales, by Drug K Unit (2015-2020)
  • Table 139. Rest of Asia-Pacific Butorphanol Sales, by Type K Unit (2015-2020)
  • Table 140. Rest of Asia-Pacific Butorphanol Sales, by Application K Unit (2015-2020)
  • Table 141. Rest of Asia-Pacific Butorphanol Sales, by Drug K Unit (2015-2020)
  • Table 142. Europe Butorphanol Sales, by Country K Unit (2015-2020)
  • Table 143. Europe Butorphanol Sales, by Type K Unit (2015-2020)
  • Table 144. Europe Butorphanol Sales, by Application K Unit (2015-2020)
  • Table 145. Europe Butorphanol Sales, by Drug K Unit (2015-2020)
  • Table 146. Germany Butorphanol Sales, by Type K Unit (2015-2020)
  • Table 147. Germany Butorphanol Sales, by Application K Unit (2015-2020)
  • Table 148. Germany Butorphanol Sales, by Drug K Unit (2015-2020)
  • Table 149. France Butorphanol Sales, by Type K Unit (2015-2020)
  • Table 150. France Butorphanol Sales, by Application K Unit (2015-2020)
  • Table 151. France Butorphanol Sales, by Drug K Unit (2015-2020)
  • Table 152. Italy Butorphanol Sales, by Type K Unit (2015-2020)
  • Table 153. Italy Butorphanol Sales, by Application K Unit (2015-2020)
  • Table 154. Italy Butorphanol Sales, by Drug K Unit (2015-2020)
  • Table 155. United Kingdom Butorphanol Sales, by Type K Unit (2015-2020)
  • Table 156. United Kingdom Butorphanol Sales, by Application K Unit (2015-2020)
  • Table 157. United Kingdom Butorphanol Sales, by Drug K Unit (2015-2020)
  • Table 158. Netherlands Butorphanol Sales, by Type K Unit (2015-2020)
  • Table 159. Netherlands Butorphanol Sales, by Application K Unit (2015-2020)
  • Table 160. Netherlands Butorphanol Sales, by Drug K Unit (2015-2020)
  • Table 161. Rest of Europe Butorphanol Sales, by Type K Unit (2015-2020)
  • Table 162. Rest of Europe Butorphanol Sales, by Application K Unit (2015-2020)
  • Table 163. Rest of Europe Butorphanol Sales, by Drug K Unit (2015-2020)
  • Table 164. MEA Butorphanol Sales, by Country K Unit (2015-2020)
  • Table 165. MEA Butorphanol Sales, by Type K Unit (2015-2020)
  • Table 166. MEA Butorphanol Sales, by Application K Unit (2015-2020)
  • Table 167. MEA Butorphanol Sales, by Drug K Unit (2015-2020)
  • Table 168. Middle East Butorphanol Sales, by Type K Unit (2015-2020)
  • Table 169. Middle East Butorphanol Sales, by Application K Unit (2015-2020)
  • Table 170. Middle East Butorphanol Sales, by Drug K Unit (2015-2020)
  • Table 171. Africa Butorphanol Sales, by Type K Unit (2015-2020)
  • Table 172. Africa Butorphanol Sales, by Application K Unit (2015-2020)
  • Table 173. Africa Butorphanol Sales, by Drug K Unit (2015-2020)
  • Table 174. North America Butorphanol Sales, by Country K Unit (2015-2020)
  • Table 175. North America Butorphanol Sales, by Type K Unit (2015-2020)
  • Table 176. North America Butorphanol Sales, by Application K Unit (2015-2020)
  • Table 177. North America Butorphanol Sales, by Drug K Unit (2015-2020)
  • Table 178. United States Butorphanol Sales, by Type K Unit (2015-2020)
  • Table 179. United States Butorphanol Sales, by Application K Unit (2015-2020)
  • Table 180. United States Butorphanol Sales, by Drug K Unit (2015-2020)
  • Table 181. Canada Butorphanol Sales, by Type K Unit (2015-2020)
  • Table 182. Canada Butorphanol Sales, by Application K Unit (2015-2020)
  • Table 183. Canada Butorphanol Sales, by Drug K Unit (2015-2020)
  • Table 184. Mexico Butorphanol Sales, by Type K Unit (2015-2020)
  • Table 185. Mexico Butorphanol Sales, by Application K Unit (2015-2020)
  • Table 186. Mexico Butorphanol Sales, by Drug K Unit (2015-2020)
  • Table 187. Butorphanol: by Type(USD/Units)
  • Table 188. Company Basic Information, Sales Area and Its Competitors
  • Table 189. Company Basic Information, Sales Area and Its Competitors
  • Table 190. Company Basic Information, Sales Area and Its Competitors
  • Table 191. Company Basic Information, Sales Area and Its Competitors
  • Table 192. Company Basic Information, Sales Area and Its Competitors
  • Table 193. Company Basic Information, Sales Area and Its Competitors
  • Table 194. Company Basic Information, Sales Area and Its Competitors
  • Table 195. Company Basic Information, Sales Area and Its Competitors
  • Table 196. Company Basic Information, Sales Area and Its Competitors
  • Table 197. Company Basic Information, Sales Area and Its Competitors
  • Table 198. Butorphanol: by Type(USD Million)
  • Table 199. Butorphanol Spray , by Region USD Million (2021-2026)
  • Table 200. Butorphanol Injection , by Region USD Million (2021-2026)
  • Table 201. Butorphanol Tablet , by Region USD Million (2021-2026)
  • Table 202. Butorphanol: by Application(USD Million)
  • Table 203. Butorphanol Human , by Region USD Million (2021-2026)
  • Table 204. Butorphanol Veterinary , by Region USD Million (2021-2026)
  • Table 205. Butorphanol: by Drug(USD Million)
  • Table 206. Butorphanol Prescripted , by Region USD Million (2021-2026)
  • Table 207. Butorphanol OTC , by Region USD Million (2021-2026)
  • Table 208. South America Butorphanol, by Country USD Million (2021-2026)
  • Table 209. South America Butorphanol, by Type USD Million (2021-2026)
  • Table 210. South America Butorphanol, by Application USD Million (2021-2026)
  • Table 211. South America Butorphanol, by Drug USD Million (2021-2026)
  • Table 212. Brazil Butorphanol, by Type USD Million (2021-2026)
  • Table 213. Brazil Butorphanol, by Application USD Million (2021-2026)
  • Table 214. Brazil Butorphanol, by Drug USD Million (2021-2026)
  • Table 215. Argentina Butorphanol, by Type USD Million (2021-2026)
  • Table 216. Argentina Butorphanol, by Application USD Million (2021-2026)
  • Table 217. Argentina Butorphanol, by Drug USD Million (2021-2026)
  • Table 218. Rest of South America Butorphanol, by Type USD Million (2021-2026)
  • Table 219. Rest of South America Butorphanol, by Application USD Million (2021-2026)
  • Table 220. Rest of South America Butorphanol, by Drug USD Million (2021-2026)
  • Table 221. Asia Pacific Butorphanol, by Country USD Million (2021-2026)
  • Table 222. Asia Pacific Butorphanol, by Type USD Million (2021-2026)
  • Table 223. Asia Pacific Butorphanol, by Application USD Million (2021-2026)
  • Table 224. Asia Pacific Butorphanol, by Drug USD Million (2021-2026)
  • Table 225. China Butorphanol, by Type USD Million (2021-2026)
  • Table 226. China Butorphanol, by Application USD Million (2021-2026)
  • Table 227. China Butorphanol, by Drug USD Million (2021-2026)
  • Table 228. Japan Butorphanol, by Type USD Million (2021-2026)
  • Table 229. Japan Butorphanol, by Application USD Million (2021-2026)
  • Table 230. Japan Butorphanol, by Drug USD Million (2021-2026)
  • Table 231. India Butorphanol, by Type USD Million (2021-2026)
  • Table 232. India Butorphanol, by Application USD Million (2021-2026)
  • Table 233. India Butorphanol, by Drug USD Million (2021-2026)
  • Table 234. South Korea Butorphanol, by Type USD Million (2021-2026)
  • Table 235. South Korea Butorphanol, by Application USD Million (2021-2026)
  • Table 236. South Korea Butorphanol, by Drug USD Million (2021-2026)
  • Table 237. Taiwan Butorphanol, by Type USD Million (2021-2026)
  • Table 238. Taiwan Butorphanol, by Application USD Million (2021-2026)
  • Table 239. Taiwan Butorphanol, by Drug USD Million (2021-2026)
  • Table 240. Australia Butorphanol, by Type USD Million (2021-2026)
  • Table 241. Australia Butorphanol, by Application USD Million (2021-2026)
  • Table 242. Australia Butorphanol, by Drug USD Million (2021-2026)
  • Table 243. Rest of Asia-Pacific Butorphanol, by Type USD Million (2021-2026)
  • Table 244. Rest of Asia-Pacific Butorphanol, by Application USD Million (2021-2026)
  • Table 245. Rest of Asia-Pacific Butorphanol, by Drug USD Million (2021-2026)
  • Table 246. Europe Butorphanol, by Country USD Million (2021-2026)
  • Table 247. Europe Butorphanol, by Type USD Million (2021-2026)
  • Table 248. Europe Butorphanol, by Application USD Million (2021-2026)
  • Table 249. Europe Butorphanol, by Drug USD Million (2021-2026)
  • Table 250. Germany Butorphanol, by Type USD Million (2021-2026)
  • Table 251. Germany Butorphanol, by Application USD Million (2021-2026)
  • Table 252. Germany Butorphanol, by Drug USD Million (2021-2026)
  • Table 253. France Butorphanol, by Type USD Million (2021-2026)
  • Table 254. France Butorphanol, by Application USD Million (2021-2026)
  • Table 255. France Butorphanol, by Drug USD Million (2021-2026)
  • Table 256. Italy Butorphanol, by Type USD Million (2021-2026)
  • Table 257. Italy Butorphanol, by Application USD Million (2021-2026)
  • Table 258. Italy Butorphanol, by Drug USD Million (2021-2026)
  • Table 259. United Kingdom Butorphanol, by Type USD Million (2021-2026)
  • Table 260. United Kingdom Butorphanol, by Application USD Million (2021-2026)
  • Table 261. United Kingdom Butorphanol, by Drug USD Million (2021-2026)
  • Table 262. Netherlands Butorphanol, by Type USD Million (2021-2026)
  • Table 263. Netherlands Butorphanol, by Application USD Million (2021-2026)
  • Table 264. Netherlands Butorphanol, by Drug USD Million (2021-2026)
  • Table 265. Rest of Europe Butorphanol, by Type USD Million (2021-2026)
  • Table 266. Rest of Europe Butorphanol, by Application USD Million (2021-2026)
  • Table 267. Rest of Europe Butorphanol, by Drug USD Million (2021-2026)
  • Table 268. MEA Butorphanol, by Country USD Million (2021-2026)
  • Table 269. MEA Butorphanol, by Type USD Million (2021-2026)
  • Table 270. MEA Butorphanol, by Application USD Million (2021-2026)
  • Table 271. MEA Butorphanol, by Drug USD Million (2021-2026)
  • Table 272. Middle East Butorphanol, by Type USD Million (2021-2026)
  • Table 273. Middle East Butorphanol, by Application USD Million (2021-2026)
  • Table 274. Middle East Butorphanol, by Drug USD Million (2021-2026)
  • Table 275. Africa Butorphanol, by Type USD Million (2021-2026)
  • Table 276. Africa Butorphanol, by Application USD Million (2021-2026)
  • Table 277. Africa Butorphanol, by Drug USD Million (2021-2026)
  • Table 278. North America Butorphanol, by Country USD Million (2021-2026)
  • Table 279. North America Butorphanol, by Type USD Million (2021-2026)
  • Table 280. North America Butorphanol, by Application USD Million (2021-2026)
  • Table 281. North America Butorphanol, by Drug USD Million (2021-2026)
  • Table 282. United States Butorphanol, by Type USD Million (2021-2026)
  • Table 283. United States Butorphanol, by Application USD Million (2021-2026)
  • Table 284. United States Butorphanol, by Drug USD Million (2021-2026)
  • Table 285. Canada Butorphanol, by Type USD Million (2021-2026)
  • Table 286. Canada Butorphanol, by Application USD Million (2021-2026)
  • Table 287. Canada Butorphanol, by Drug USD Million (2021-2026)
  • Table 288. Mexico Butorphanol, by Type USD Million (2021-2026)
  • Table 289. Mexico Butorphanol, by Application USD Million (2021-2026)
  • Table 290. Mexico Butorphanol, by Drug USD Million (2021-2026)
  • Table 291. Butorphanol Sales: by Type(K Unit)
  • Table 292. Butorphanol Sales Spray , by Region K Unit (2021-2026)
  • Table 293. Butorphanol Sales Injection , by Region K Unit (2021-2026)
  • Table 294. Butorphanol Sales Tablet , by Region K Unit (2021-2026)
  • Table 295. Butorphanol Sales: by Application(K Unit)
  • Table 296. Butorphanol Sales Human , by Region K Unit (2021-2026)
  • Table 297. Butorphanol Sales Veterinary , by Region K Unit (2021-2026)
  • Table 298. Butorphanol Sales: by Drug(K Unit)
  • Table 299. Butorphanol Sales Prescripted , by Region K Unit (2021-2026)
  • Table 300. Butorphanol Sales OTC , by Region K Unit (2021-2026)
  • Table 301. South America Butorphanol Sales, by Country K Unit (2021-2026)
  • Table 302. South America Butorphanol Sales, by Type K Unit (2021-2026)
  • Table 303. South America Butorphanol Sales, by Application K Unit (2021-2026)
  • Table 304. South America Butorphanol Sales, by Drug K Unit (2021-2026)
  • Table 305. Brazil Butorphanol Sales, by Type K Unit (2021-2026)
  • Table 306. Brazil Butorphanol Sales, by Application K Unit (2021-2026)
  • Table 307. Brazil Butorphanol Sales, by Drug K Unit (2021-2026)
  • Table 308. Argentina Butorphanol Sales, by Type K Unit (2021-2026)
  • Table 309. Argentina Butorphanol Sales, by Application K Unit (2021-2026)
  • Table 310. Argentina Butorphanol Sales, by Drug K Unit (2021-2026)
  • Table 311. Rest of South America Butorphanol Sales, by Type K Unit (2021-2026)
  • Table 312. Rest of South America Butorphanol Sales, by Application K Unit (2021-2026)
  • Table 313. Rest of South America Butorphanol Sales, by Drug K Unit (2021-2026)
  • Table 314. Asia Pacific Butorphanol Sales, by Country K Unit (2021-2026)
  • Table 315. Asia Pacific Butorphanol Sales, by Type K Unit (2021-2026)
  • Table 316. Asia Pacific Butorphanol Sales, by Application K Unit (2021-2026)
  • Table 317. Asia Pacific Butorphanol Sales, by Drug K Unit (2021-2026)
  • Table 318. China Butorphanol Sales, by Type K Unit (2021-2026)
  • Table 319. China Butorphanol Sales, by Application K Unit (2021-2026)
  • Table 320. China Butorphanol Sales, by Drug K Unit (2021-2026)
  • Table 321. Japan Butorphanol Sales, by Type K Unit (2021-2026)
  • Table 322. Japan Butorphanol Sales, by Application K Unit (2021-2026)
  • Table 323. Japan Butorphanol Sales, by Drug K Unit (2021-2026)
  • Table 324. India Butorphanol Sales, by Type K Unit (2021-2026)
  • Table 325. India Butorphanol Sales, by Application K Unit (2021-2026)
  • Table 326. India Butorphanol Sales, by Drug K Unit (2021-2026)
  • Table 327. South Korea Butorphanol Sales, by Type K Unit (2021-2026)
  • Table 328. South Korea Butorphanol Sales, by Application K Unit (2021-2026)
  • Table 329. South Korea Butorphanol Sales, by Drug K Unit (2021-2026)
  • Table 330. Taiwan Butorphanol Sales, by Type K Unit (2021-2026)
  • Table 331. Taiwan Butorphanol Sales, by Application K Unit (2021-2026)
  • Table 332. Taiwan Butorphanol Sales, by Drug K Unit (2021-2026)
  • Table 333. Australia Butorphanol Sales, by Type K Unit (2021-2026)
  • Table 334. Australia Butorphanol Sales, by Application K Unit (2021-2026)
  • Table 335. Australia Butorphanol Sales, by Drug K Unit (2021-2026)
  • Table 336. Rest of Asia-Pacific Butorphanol Sales, by Type K Unit (2021-2026)
  • Table 337. Rest of Asia-Pacific Butorphanol Sales, by Application K Unit (2021-2026)
  • Table 338. Rest of Asia-Pacific Butorphanol Sales, by Drug K Unit (2021-2026)
  • Table 339. Europe Butorphanol Sales, by Country K Unit (2021-2026)
  • Table 340. Europe Butorphanol Sales, by Type K Unit (2021-2026)
  • Table 341. Europe Butorphanol Sales, by Application K Unit (2021-2026)
  • Table 342. Europe Butorphanol Sales, by Drug K Unit (2021-2026)
  • Table 343. Germany Butorphanol Sales, by Type K Unit (2021-2026)
  • Table 344. Germany Butorphanol Sales, by Application K Unit (2021-2026)
  • Table 345. Germany Butorphanol Sales, by Drug K Unit (2021-2026)
  • Table 346. France Butorphanol Sales, by Type K Unit (2021-2026)
  • Table 347. France Butorphanol Sales, by Application K Unit (2021-2026)
  • Table 348. France Butorphanol Sales, by Drug K Unit (2021-2026)
  • Table 349. Italy Butorphanol Sales, by Type K Unit (2021-2026)
  • Table 350. Italy Butorphanol Sales, by Application K Unit (2021-2026)
  • Table 351. Italy Butorphanol Sales, by Drug K Unit (2021-2026)
  • Table 352. United Kingdom Butorphanol Sales, by Type K Unit (2021-2026)
  • Table 353. United Kingdom Butorphanol Sales, by Application K Unit (2021-2026)
  • Table 354. United Kingdom Butorphanol Sales, by Drug K Unit (2021-2026)
  • Table 355. Netherlands Butorphanol Sales, by Type K Unit (2021-2026)
  • Table 356. Netherlands Butorphanol Sales, by Application K Unit (2021-2026)
  • Table 357. Netherlands Butorphanol Sales, by Drug K Unit (2021-2026)
  • Table 358. Rest of Europe Butorphanol Sales, by Type K Unit (2021-2026)
  • Table 359. Rest of Europe Butorphanol Sales, by Application K Unit (2021-2026)
  • Table 360. Rest of Europe Butorphanol Sales, by Drug K Unit (2021-2026)
  • Table 361. MEA Butorphanol Sales, by Country K Unit (2021-2026)
  • Table 362. MEA Butorphanol Sales, by Type K Unit (2021-2026)
  • Table 363. MEA Butorphanol Sales, by Application K Unit (2021-2026)
  • Table 364. MEA Butorphanol Sales, by Drug K Unit (2021-2026)
  • Table 365. Middle East Butorphanol Sales, by Type K Unit (2021-2026)
  • Table 366. Middle East Butorphanol Sales, by Application K Unit (2021-2026)
  • Table 367. Middle East Butorphanol Sales, by Drug K Unit (2021-2026)
  • Table 368. Africa Butorphanol Sales, by Type K Unit (2021-2026)
  • Table 369. Africa Butorphanol Sales, by Application K Unit (2021-2026)
  • Table 370. Africa Butorphanol Sales, by Drug K Unit (2021-2026)
  • Table 371. North America Butorphanol Sales, by Country K Unit (2021-2026)
  • Table 372. North America Butorphanol Sales, by Type K Unit (2021-2026)
  • Table 373. North America Butorphanol Sales, by Application K Unit (2021-2026)
  • Table 374. North America Butorphanol Sales, by Drug K Unit (2021-2026)
  • Table 375. United States Butorphanol Sales, by Type K Unit (2021-2026)
  • Table 376. United States Butorphanol Sales, by Application K Unit (2021-2026)
  • Table 377. United States Butorphanol Sales, by Drug K Unit (2021-2026)
  • Table 378. Canada Butorphanol Sales, by Type K Unit (2021-2026)
  • Table 379. Canada Butorphanol Sales, by Application K Unit (2021-2026)
  • Table 380. Canada Butorphanol Sales, by Drug K Unit (2021-2026)
  • Table 381. Mexico Butorphanol Sales, by Type K Unit (2021-2026)
  • Table 382. Mexico Butorphanol Sales, by Application K Unit (2021-2026)
  • Table 383. Mexico Butorphanol Sales, by Drug K Unit (2021-2026)
  • Table 384. Butorphanol: by Type(USD/Units)
  • Table 385. Research Programs/Design for This Report
  • Table 386. Key Data Information from Secondary Sources
  • Table 387. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Butorphanol: by Type USD Million (2015-2020)
  • Figure 5. Global Butorphanol: by Application USD Million (2015-2020)
  • Figure 6. Global Butorphanol: by Drug USD Million (2015-2020)
  • Figure 7. South America Butorphanol Share (%), by Country
  • Figure 8. Asia Pacific Butorphanol Share (%), by Country
  • Figure 9. Europe Butorphanol Share (%), by Country
  • Figure 10. MEA Butorphanol Share (%), by Country
  • Figure 11. North America Butorphanol Share (%), by Country
  • Figure 12. Global Butorphanol: by Type K Unit (2015-2020)
  • Figure 13. Global Butorphanol: by Application K Unit (2015-2020)
  • Figure 14. Global Butorphanol: by Drug K Unit (2015-2020)
  • Figure 15. South America Butorphanol Share (%), by Country
  • Figure 16. Asia Pacific Butorphanol Share (%), by Country
  • Figure 17. Europe Butorphanol Share (%), by Country
  • Figure 18. MEA Butorphanol Share (%), by Country
  • Figure 19. North America Butorphanol Share (%), by Country
  • Figure 20. Global Butorphanol: by Type USD/Units (2015-2020)
  • Figure 21. Global Butorphanol share by Players 2020 (%)
  • Figure 22. Global Butorphanol share by Players (Top 3) 2020(%)
  • Figure 23. Global Butorphanol share by Players (Top 5) 2020(%)
  • Figure 24. BCG Matrix for key Companies
  • Figure 25. Hikma Pharmaceuticals plc (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 26. Hikma Pharmaceuticals plc (United Kingdom) Revenue: by Geography 2020
  • Figure 27. Richter Pharma Ag (Austria) Revenue, Net Income and Gross profit
  • Figure 28. Richter Pharma Ag (Austria) Revenue: by Geography 2020
  • Figure 29. Mylan N.V. (United States) Revenue, Net Income and Gross profit
  • Figure 30. Mylan N.V. (United States) Revenue: by Geography 2020
  • Figure 31. Pfizer Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 32. Pfizer Inc. (United States) Revenue: by Geography 2020
  • Figure 33. Sanochemia Pharmazeutika AG (Austria) Revenue, Net Income and Gross profit
  • Figure 34. Sanochemia Pharmazeutika AG (Austria) Revenue: by Geography 2020
  • Figure 35. Novex Pharma (Egypt) Revenue, Net Income and Gross profit
  • Figure 36. Novex Pharma (Egypt) Revenue: by Geography 2020
  • Figure 37. Selectavet (Germany) Revenue, Net Income and Gross profit
  • Figure 38. Selectavet (Germany) Revenue: by Geography 2020
  • Figure 39. Bristol Myers Squibb (United States) Revenue, Net Income and Gross profit
  • Figure 40. Bristol Myers Squibb (United States) Revenue: by Geography 2020
  • Figure 41. Dechra Pharmaceuticals PLC (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 42. Dechra Pharmaceuticals PLC (United Kingdom) Revenue: by Geography 2020
  • Figure 43. Merck Group (Germany) Revenue, Net Income and Gross profit
  • Figure 44. Merck Group (Germany) Revenue: by Geography 2020
  • Figure 45. Global Butorphanol: by Type USD Million (2021-2026)
  • Figure 46. Global Butorphanol: by Application USD Million (2021-2026)
  • Figure 47. Global Butorphanol: by Drug USD Million (2021-2026)
  • Figure 48. South America Butorphanol Share (%), by Country
  • Figure 49. Asia Pacific Butorphanol Share (%), by Country
  • Figure 50. Europe Butorphanol Share (%), by Country
  • Figure 51. MEA Butorphanol Share (%), by Country
  • Figure 52. North America Butorphanol Share (%), by Country
  • Figure 53. Global Butorphanol: by Type K Unit (2021-2026)
  • Figure 54. Global Butorphanol: by Application K Unit (2021-2026)
  • Figure 55. Global Butorphanol: by Drug K Unit (2021-2026)
  • Figure 56. South America Butorphanol Share (%), by Country
  • Figure 57. Asia Pacific Butorphanol Share (%), by Country
  • Figure 58. Europe Butorphanol Share (%), by Country
  • Figure 59. MEA Butorphanol Share (%), by Country
  • Figure 60. North America Butorphanol Share (%), by Country
  • Figure 61. Global Butorphanol: by Type USD/Units (2021-2026)
List of companies from research coverage that are profiled in the study
  • Hikma Pharmaceuticals plc (United Kingdom)
  • Richter Pharma Ag (Austria)
  • Mylan N.V. (United States)
  • Pfizer Inc. (United States)
  • Sanochemia Pharmazeutika AG (Austria)
  • Novex Pharma (Egypt)
  • Selectavet (Germany)
  • Bristol Myers Squibb (United States)
  • Dechra Pharmaceuticals PLC (United Kingdom)
  • Merck Group (Germany)
Additional players considered in the study are as follows:
Apothecon Pharmaceuticals (India) , Faunapharma (Finland)
Select User Access Type

Key Highlights of Report


Feb 2021 233 Pages 74 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Butorphanol Market Quantitative research analysis
Global Butorphanol Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Know More About Global Butorphanol Market Report?

Have a Query? Click Here

Other Related Reports

Head Lice Drug Comprehensive Study by Type (OTC Medication (Permethrin, Pyrethrin, Other), Prescription Medication (Ivermectin, Spinosad, Malathion, Other)), Application (Children, Adult), Form (Loti...
$ 3650
Swallowing Disorder Products Comprehensive Study by Type (Food Products, Powder Thickener, Ready-to-drink thickened beverages, Oral nutritional supplements, Feeding Aids & Tubes), Sales Distribution ...
$ 3450
Panacis Quinquefolis Comprehensive Study by Application (Anxiety, Mental Disorder, Menopause, Type 2 Diabetes, Heart Disease, Cancer, Alzheimer), Form (Fragment, Capsule, Powder, Others), Parts Used ...
$ 3500
Ossotide Tablets Comprehensive Study by Application (Fractures, Osteoarthritis, Rheumatism, Rheumatoid Arthritis), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online) Players and Re...
$ 3500
Bacampicillin Comprehensive Study by Application (Pneumonia, Bronchitis, Tract Infections, Skin Infections, Others), Patient Type (Adult, Pediatric), Distribution Channel (Hospital Pharmacy, Online P...
$ 3450
Neutropenia Drugs Comprehensive Study by Type (Congenital Neutropenia, Idiopathic, Cyclic Neutropenia, Autoimmune Neutropenia), By Drug type (Capsule, Injection), End User (Hospital, Clinics) Players...
$ 3500